Adalat cc and Infection - a phase IV clinical study of FDA data

Summary:

Infection is reported as a side effect among people who take Adalat cc (nifedipine), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Humulin R, and have Metastases to bone.

The phase IV clinical study analyzes which people have Infection when taking Adalat cc. It is created by eHealthMe based on reports of 4,914 people who have side effects when taking Adalat cc from the FDA, and is updated regularly.

What is Adalat cc?

Adalat cc has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 5,019 Adalat cc users. Check the latest studies of Adalat cc.

What is Infection?

Infection is found to be associated with 2,505 drugs and 2,590 conditions by eHealthMe. Check the latest studies of Infection.

On Jul, 04, 2026

4,914 people reported to have side effects when taking Adalat cc.
Among them, 39 people (0.79%) have Infection.

Among these 39 people:

How long have people been on Adalat cc when they have Infection? *

What is the gender of people who have Infection when taking Adalat cc? *

female: 31.58 %
male: 68.42 %

What is the age of people who have Infection when taking Adalat cc? *

What are other drugs people take besides Adalat cc? *

What are other side effects people have besides Infection? *

Pneumonia: 16 people, 41.03%
Diarrhea: 14 people, 35.90%
Decreased Activity: 12 people, 30.77%
Joint Pain: 12 people, 30.77%
Dyspnea (difficult or laboured breathing): 11 people, 28.21%
Blood Creatinine Increased: 11 people, 28.21%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 25.64%
Inflammation: 10 people, 25.64%
Cardiac Arrest: 10 people, 25.64%
Pain In Extremity: 10 people, 25.64%

What are the existing conditions these people have? *

Pain: 9 people, 23.08%
Metastases To Bone (cancer spreads to bone): 9 people, 23.08%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.26%
Multiple Myeloma (cancer of the plasma cells): 4 people, 10.26%
Myeloma Recurrence (recurrence of cancer of the plasma cells - a kind of white blood cell): 3 people, 7.69%
Diabetes: 2 people, 5.13%
Type 1 Diabetes: 2 people, 5.13%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 5.13%
Latent Autoimmune Diabetes In Adults (slow progressing diabetes in adult): 2 people, 5.13%
Chronic Renal Failure (kidney failure): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat cc and have Infection?

- Check whether Infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat cc:

Adalat cc (5,019 reports)

Infection treatments and more:

Infection (201,697 reports)

Browse all side effects of Adalat cc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infection:

Infection (2,505 drugs)

Browse all the conditions that are associated with Infection:

Infection (2,590 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat cc) and Adalat cc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.